Central Trust Company’s Select Medical SEM Stock Holding History

Central Trust Company’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-30	Closed	-$414	–	1285
2023 Q1	$414	Hold	30	–	–	﹤0.01%	1251
2022 Q4	$397	Hold	30	–	–	﹤0.01%	1232
2022 Q3	$0	Hold	30	–	–	﹤0.01%	1403
2022 Q2	$0	Sell	30 -217	-88%	-$2.79K	﹤0.01%	1445
2022 Q1	$3K	Buy	+247	New	+$3.26K	﹤0.01%	1218

Other funds holding SEM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Central Trust Company's SEM Position: Q2 2023 in Review

Central Trust Company sold out of Select Medical (SEM) in Q2 2023, closing a stake of 30 shares — an estimated $414 sold.

Central Trust Company first reported a position in SEM in Q1 2022 and held it in 5 quarters. The position peaked at $3K in Q1 2022. 226 funds tracked by Wall St. Rank hold SEM as of Q2 2023.

Central Trust Company reported no remaining Select Medical position as of Q2 2023 after selling out during the quarter.
Central Trust Company sold 30 Select Medical shares in Q2 2023, an estimated $414.
Central Trust Company first reported a position in Select Medical in Q1 2022 and held it in 5 quarters.
Central Trust Company's Select Medical position peaked at $3K in Q1 2022.
226 funds tracked by Wall St. Rank held Select Medical as of Q2 2023.

Based on Central Trust Company's 13F filing for Q2 2023, filed 26 Jul 2023.